Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

Cited In for PubMed (Select 17091130)

1.

Regional brain [(11)C]carfentanil binding following tobacco smoking.

Domino EF, Hirasawa-Fujita M, Ni L, Guthrie SK, Zubieta JK.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jun 3;59:100-4. doi: 10.1016/j.pnpbp.2015.01.007. Epub 2015 Jan 15.

PMID:
25598501
2.

Sex differences in the brain's dopamine signature of cigarette smoking.

Cosgrove KP, Wang S, Kim SJ, McGovern E, Nabulsi N, Gao H, Labaree D, Tagare HD, Sullivan JM, Morris ED.

J Neurosci. 2014 Dec 10;34(50):16851-5. doi: 10.1523/JNEUROSCI.3661-14.2014.

3.

Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers.

Kuwabara H, Heishman SJ, Brasic JR, Contoreggi C, Cascella N, Mackowick KM, Taylor R, Rousset O, Willis W, Huestis MA, Concheiro M, Wand G, Wong DF, Volkow ND.

PLoS One. 2014 Dec 10;9(12):e113694. doi: 10.1371/journal.pone.0113694. eCollection 2014.

4.

Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy.

Greenwald MK, Comer SD, Fiellin DA.

Drug Alcohol Depend. 2014 Nov 1;144:1-11. doi: 10.1016/j.drugalcdep.2014.07.035. Epub 2014 Aug 19.

PMID:
25179217
5.

Neuroadaptive changes associated with smoking: structural and functional neural changes in nicotine dependence.

Martin-Soelch C.

Brain Sci. 2013 Feb 15;3(1):159-76. doi: 10.3390/brainsci3010159.

6.

Disrupted topological organization in whole-brain functional networks of heroin-dependent individuals: a resting-state FMRI study.

Jiang G, Wen X, Qiu Y, Zhang R, Wang J, Li M, Ma X, Tian J, Huang R.

PLoS One. 2013 Dec 17;8(12):e82715. doi: 10.1371/journal.pone.0082715. eCollection 2013.

7.

Imaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [(11)C]PHNO vs [(11)C]raclopride PET.

Gallezot JD, Kloczynski T, Weinzimmer D, Labaree D, Zheng MQ, Lim K, Rabiner EA, Ridler K, Pittman B, Huang Y, Carson RE, Morris ED, Cosgrove KP.

Neuropsychopharmacology. 2014 Mar;39(4):866-74. doi: 10.1038/npp.2013.286. Epub 2013 Oct 15.

8.

Creating dynamic images of short-lived dopamine fluctuations with lp-ntPET: dopamine movies of cigarette smoking.

Morris ED, Kim SJ, Sullivan JM, Wang S, Normandin MD, Constantinescu CC, Cosgrove KP.

J Vis Exp. 2013 Aug 6;(78). doi: 10.3791/50358.

9.

No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT.

Thomsen G, Knudsen GM, Jensen PS, Ziebell M, Holst KK, Asenbaum S, Booij J, Darcourt J, Dickson JC, Kapucu OL, Nobili F, Sabri O, Sera T, Tatsch K, Tossici-Bolt L, Laere KV, Borght TV, Varrone A, Pagani M, Pinborg LH.

EJNMMI Res. 2013 May 20;3(1):39. doi: 10.1186/2191-219X-3-39.

10.

Limitations of SRTM, Logan graphical method, and equilibrium analysis for measuring transient dopamine release with [(11)C]raclopride PET.

Sullivan JM, Kim SJ, Cosgrove KP, Morris ED.

Am J Nucl Med Mol Imaging. 2013 Apr 9;3(3):247-60. Print 2013.

11.

Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans.

Jasinska AJ, Zorick T, Brody AL, Stein EA.

Neuropharmacology. 2014 Sep;84:111-22. doi: 10.1016/j.neuropharm.2013.02.015. Epub 2013 Mar 6. Review.

12.

Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects.

Weerts EM, Wand GS, Kuwabara H, Xu X, Frost JJ, Wong DF, McCaul ME.

Addict Biol. 2014 Jul;19(4):733-42. doi: 10.1111/adb.12022. Epub 2012 Dec 18.

13.

Effects of amphetamine on the human brain opioid system--a positron emission tomography study.

Guterstam J, Jayaram-Lindström N, Cervenka S, Frost JJ, Farde L, Halldin C, Franck J.

Int J Neuropsychopharmacol. 2013 May;16(4):763-9. doi: 10.1017/S1461145712000818. Epub 2012 Aug 29.

14.

Denicotinized versus average nicotine tobacco cigarette smoking differentially releases striatal dopamine.

Domino EF, Ni L, Domino JS, Yang W, Evans C, Guthrie S, Wang H, Koeppe RA, Zubieta JK.

Nicotine Tob Res. 2013 Jan;15(1):11-21. doi: 10.1093/ntr/nts029. Epub 2012 Apr 5.

15.

μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief.

Falcone M, Gold AB, Wileyto EP, Ray R, Ruparel K, Newberg A, Dubroff J, Logan J, Zubieta JK, Blendy JA, Lerman C.

Psychopharmacology (Berl). 2012 Aug;222(4):701-8. doi: 10.1007/s00213-012-2673-5. Epub 2012 Mar 3.

16.

Acute phenylalanine/tyrosine depletion reduces motivation to smoke cigarettes across stages of addiction.

Venugopalan VV, Casey KF, O'Hara C, O'Loughlin J, Benkelfat C, Fellows LK, Leyton M.

Neuropsychopharmacology. 2011 Nov;36(12):2469-76. doi: 10.1038/npp.2011.135. Epub 2011 Jul 20.

17.

Varenicline as a smoking cessation aid in schizophrenia: effects on smoking behavior and reward sensitivity.

Dutra SJ, Stoeckel LE, Carlini SV, Pizzagalli DA, Evins AE.

Psychopharmacology (Berl). 2012 Jan;219(1):25-34. doi: 10.1007/s00213-011-2373-6. Epub 2011 Jun 22.

18.

Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers.

Ray R, Ruparel K, Newberg A, Wileyto EP, Loughead JW, Divgi C, Blendy JA, Logan J, Zubieta JK, Lerman C.

Proc Natl Acad Sci U S A. 2011 May 31;108(22):9268-73. doi: 10.1073/pnas.1018699108. Epub 2011 May 16.

19.

The effects of depression and smoking on pain severity and opioid use in patients with chronic pain.

Hooten WM, Shi Y, Gazelka HM, Warner DO.

Pain. 2011 Jan;152(1):223-9. doi: 10.1016/j.pain.2010.10.045. Epub 2010 Dec 3.

20.

Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for Tobacco Dependence.

Brody AL, London ED, Olmstead RE, Allen-Martinez Z, Shulenberger S, Costello MR, Abrams AL, Scheibal D, Farahi J, Shoptaw S, Mandelkern MA.

Psychiatry Res. 2010 Sep 30;183(3):218-24. doi: 10.1016/j.pscychresns.2009.06.004. Epub 2010 Aug 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk